D-chiro-inositol & Endometrial Thickness NCT05283642

Updated 05/17/2024

Clinical Trial Details — Status: Completed

Administrative data
NCT number	NCT05283642
Other study ID #	DCI_GYN22
Secondary ID
Status	Completed
Phase	N/A
First received
Last updated
Start date	March 8, 2022
Est. completion date	December 20, 2022

Study information
Verified date	March 2022
Source	Lo.Li.Pharma s.r.l
Contact	n/a
Is FDA regulated	No
Health authority
Study type	Interventional

Clinical Trial Summary

Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.

Recruitment information / eligibility
Status	Completed
Enrollment	13
Est. completion date	December 20, 2022
Est. primary completion date	October 29, 2022
Accepts healthy volunteers	No
Gender	Female
Age group	18 Years to 60 Years
Eligibility	Inclusion Criteria: - altered endometrial thickness Exclusion Criteria: - patients with cancer - patients under hormonal treatments (progestogens and/or estrogens) - patients supplemented with inositols

Study Design

Related Conditions & MeSH terms

Intervention

Dietary Supplement:
• DCI
Oral supplementation with D-chiro-inositol once daily

Locations
Country	Name	City	State
Italy	ASL Umbria 2	Terni	Umbria

Sponsors *(1)*
Lead Sponsor	Collaborator
Lo.Li.Pharma s.r.l

Country where clinical trial is conducted

Italy,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Change in endometrial thickness	Change in endometrial thickness by ultrasound measurement from baseline to three months	Two time points: baseline and after three months

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05001282` - A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)	Phase 1/Phase 2
	Recruiting	`NCT04145518` - Mechanistic Characterization of Uterine Pain	Phase 4
	Recruiting	`NCT03756480` - Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
	Recruiting	`NCT03748238` - Endometrial Injury In Recurrent Implantation Failure	N/A
	Completed	`NCT03519763` - Intrauterine Microbiota During IVF in Patients Affected With Isthmocele.
	Completed	`NCT03207074` - Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?	N/A
	Recruiting	`NCT03289468` - Study of Diagnosis of Color Power Doppler Combined Minimally Invasive Sampling for Endometrial Diseases
	Completed	`NCT03755973` - Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity	Phase 4
	Withdrawn	`NCT04184323` - SIRT-1 Antagonism for Endometrial Receptivity	Phase 2
	Completed	`NCT06324851` - The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation	Phase 4
	Completed	`NCT06316180` - The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation	Phase 4
	Completed	`NCT06316206` - The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation	Phase 4
	Completed	`NCT06316219` - The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation	Phase 4
	Recruiting	`NCT06264921` - A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors	Phase 1
	Completed	`NCT03060603` - Proliferative Effects of Erythropoietin on Human Endometrium	N/A
	Completed	`NCT01808898` - Role of Intrauterine Cornual Block in Combination With Direct Cervical Block in Outpatient Endometrial Ablation	Phase 4
	Completed	`NCT05472740` - Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy	N/A
	Completed	`NCT02716636` - Fast Versus Slow Tenaculum Placement	N/A